99 related articles for article (PubMed ID: 17395367)
1. Recombinant C-terminal fragments of the gastrin-releasing peptide precursor are bioactive.
Patel O; Dumesny C; Shulkes A; Baldwin GS
Cancer Lett; 2007 Aug; 254(1):87-93. PubMed ID: 17395367
[TBL] [Abstract][Full Text] [Related]
2. C-terminal fragments of the gastrin-releasing peptide precursor stimulate cell proliferation via a novel receptor.
Patel O; Dumesny C; Shulkes A; Baldwin GS
Endocrinology; 2007 Mar; 148(3):1330-9. PubMed ID: 17122080
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, expression and biological activity of the prohormone for gastrin releasing peptide (ProGRP).
Dumesny C; Patel O; Lachal S; Giraud AS; Baldwin GS; Shulkes A
Endocrinology; 2006 Jan; 147(1):502-9. PubMed ID: 16223866
[TBL] [Abstract][Full Text] [Related]
4. Gastrin-releasing peptide: different forms, different functions.
Ischia J; Patel O; Shulkes A; Baldwin GS
Biofactors; 2009; 35(1):69-75. PubMed ID: 19319848
[TBL] [Abstract][Full Text] [Related]
5. Expression of progastrin-releasing peptide and gastrin-releasing peptide receptor mRNA transcripts in tumor cells of patients with small cell lung cancer.
Uchida K; Kojima A; Morokawa N; Tanabe O; Anzai C; Kawakami M; Eto Y; Yoshimura K
J Cancer Res Clin Oncol; 2002 Dec; 128(12):633-40. PubMed ID: 12474049
[TBL] [Abstract][Full Text] [Related]
6. Phylogenetic analysis of the sequences of gastrin-releasing peptide and its receptors: biological implications.
Baldwin GS; Patel O; Shulkes A
Regul Pept; 2007 Oct; 143(1-3):1-14. PubMed ID: 17395282
[TBL] [Abstract][Full Text] [Related]
7. Identification of binding sites for C-terminal pro-gastrin-releasing peptide (GRP)-derived peptides in renal cell carcinoma: a potential target for future therapy.
Ischia J; Patel O; Sethi K; Nordlund MS; Bolton D; Shulkes A; Baldwin GS
BJU Int; 2015 May; 115(5):829-38. PubMed ID: 25130393
[TBL] [Abstract][Full Text] [Related]
8. Systematic optimization of a lead-structure identities for a selective short peptide agonist for the human orphan receptor BRS-3.
Weber D; Berger C; Heinrich T; Eickelmann P; Antel J; Kessler H
J Pept Sci; 2002 Aug; 8(8):461-75. PubMed ID: 12212809
[TBL] [Abstract][Full Text] [Related]
9. Pharmacology and cell biology of the bombesin receptor subtype 4 (BB4-R).
Katsuno T; Pradhan TK; Ryan RR; Mantey SA; Hou W; Donohue PJ; Akeson MA; Spindel ER; Battey JF; Coy DH; Jensen RT
Biochemistry; 1999 Jun; 38(22):7307-20. PubMed ID: 10353842
[TBL] [Abstract][Full Text] [Related]
10. Identification of key amino acids in the gastrin-releasing peptide receptor (GRPR) responsible for high affinity binding of gastrin-releasing peptide (GRP).
Nakagawa T; Hocart SJ; Schumann M; Tapia JA; Mantey SA; Coy DH; Tokita K; Katsuno T; Jensen RT
Biochem Pharmacol; 2005 Feb; 69(4):579-93. PubMed ID: 15670577
[TBL] [Abstract][Full Text] [Related]
11. A novel vaccine targeting gastrin-releasing peptide: efficient inhibition of breast cancer growth in vivo.
Guojun W; Wei G; Kedong O; Yi H; Yanfei X; Qingmei C; Yankai Z; Jie W; Hao F; Taiming L; Jingjing L; Rongyue C
Endocr Relat Cancer; 2008 Mar; 15(1):149-59. PubMed ID: 18310283
[TBL] [Abstract][Full Text] [Related]
12. Pro-GRP-derived peptides are expressed in colorectal cancer cells and tumors and are biologically active in vivo.
Patel O; Clyde D; Chang M; Nordlund MS; Steel R; Kemp BE; Pritchard DM; Shulkes A; Baldwin GS
Endocrinology; 2012 Mar; 153(3):1082-92. PubMed ID: 22202166
[TBL] [Abstract][Full Text] [Related]
13. A gastrin-releasing peptide receptor antagonist stimulates Neuro2a neuroblastoma cell growth: prevention by a histone deacetylase inhibitor.
Abujamra AL; Almeida VR; Brunetto AL; Schwartsmann G; Roesler R
Cell Biol Int; 2009 Aug; 33(8):899-903. PubMed ID: 19426821
[TBL] [Abstract][Full Text] [Related]
14. Importance of amino acids of the central portion of the second intracellular loop of the gastrin-releasing Peptide receptor for phospholipase C activation, internalization, and chronic down-regulation.
Schumann M; Nakagawa T; Mantey SA; Tokita K; Venzon DJ; Hocart SJ; Benya RV; Jensen RT
J Pharmacol Exp Ther; 2003 Nov; 307(2):597-607. PubMed ID: 12970386
[TBL] [Abstract][Full Text] [Related]
15. Design, preparation, in vitro and in vivo evaluation of (99m)Tc-N2S2-Tat(49-57)-bombesin: a target-specific hybrid radiopharmaceutical.
Santos-Cuevas CL; Ferro-Flores G; Arteaga de Murphy C; Ramírez Fde M; Luna-Gutiérrez MA; Pedraza-López M; García-Becerra R; Ordaz-Rosado D
Int J Pharm; 2009 Jun; 375(1-2):75-83. PubMed ID: 19393305
[TBL] [Abstract][Full Text] [Related]
16. Stimulation of proliferation of U138-MG glioblastoma cells by gastrin-releasing peptide in combination with agents that enhance cAMP signaling.
Farias CB; Lima RC; Lima LO; Flores DG; Meurer L; Brunetto AL; Schwartsmann G; Roesler R
Oncology; 2008; 75(1-2):27-31. PubMed ID: 18719351
[TBL] [Abstract][Full Text] [Related]
17. Therapy of experimental hepatic cancers with cytotoxic peptide analogs targeted to receptors for luteinizing hormone-releasing hormone, somatostatin or bombesin.
Szepeshazi K; Schally AV; Treszl A; Seitz S; Halmos G
Anticancer Drugs; 2008 Apr; 19(4):349-58. PubMed ID: 18454045
[TBL] [Abstract][Full Text] [Related]
18. Swiss 3T3 mouse embryo fibroblasts transfected with a human prepro-GRP gene synthesize and secrete pro-GRP rather than GRP.
Lebacq-Verheyden AM; Segal S; Cuttitta F; Battey JF
J Cell Biochem; 1988 Mar; 36(3):237-48. PubMed ID: 3379103
[TBL] [Abstract][Full Text] [Related]
19. High expression of gastrin-releasing peptide receptors in the vascular bed of urinary tract cancers: promising candidates for vascular targeting applications.
Fleischmann A; Waser B; Reubi JC
Endocr Relat Cancer; 2009 Jun; 16(2):623-33. PubMed ID: 19478282
[TBL] [Abstract][Full Text] [Related]
20. Importance of N- and C-terminal regions of gastrin-Gly for preferential binding to high and low affinity gastrin-Gly receptors.
Ahmed S; Murphy RF; Lovas S
Peptides; 2005 Jul; 26(7):1207-12. PubMed ID: 15949639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
